Dr Lal Pathlabs Q4 Results: Profit dips to Rs 56.7 cr; co announces dividend of Rs 6 per share

The company said it board has approved a final dividend of Rs 6 per share on face value of Rs 10 each for the year ended March 31, 2023.

Commenting on the performance, Dr Om Manchanda, Managing Director said: "Our belief is that the brands that have made comprehensive investments in network creation, infrastructure scale up, and patient services will be the frontrunners of growth. Within healthcare, patients are increasingly aligning themselves with trustworthy brands, and therefore, it is crucial that we improve our on-theground presence and experience. In order to enhance our performance trajectory, we will continue to extend our network into tier 2 and 3 regions of India."

"Furthermore, our expansion in the West, mainly Mumbai and other large cities, will emanate from increasing the density of our collection centers. To achieve this, we are deploying hub labs as a means to amplify our capabilities. These labs will provide support to a cluster of collection centers in the surrounding areas, resulting in improved cost efficiency and faster turnaround times,” Manchanda added.

Shares of Dr Lal PathLabs Ltd were trading 1.18 percent lower at Rs 1,926.80 apiece in Thursday's trade. The stock rose 3 percent in the last one month, while on a year-to-date basis it fell 13 percent.